Search

everythinglearnresearchcommunity

for

Search:↓

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Alopecia may lower the risk of substance use disorder.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Drinking alcohol 1-2 times a week may reduce urinary symptoms, but drinking more often might increase the risk.

Heavier birth weight may increase the risk of early hair graying in women.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Major depression disorder increases the risk of alopecia areata, and vice versa.

Lower testosterone levels increase kidney stone risk in men over 40.

Certain bacteria may influence alopecia areata risk, but skin bacteria don't mediate gut-skin effects.

Gut bacteria may affect hair loss risk.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

Certain hairstyles and less hair oil use in African American girls can lead to scalp conditions like traction alopecia and seborrheic dermatitis.

Overweight smokers have worse hair loss.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

HIV-positive pregnant women are more likely to experience severe bleeding, and a pregnant woman with familial hypertriglyceridemia had a successful early delivery with special care.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.